Pre-eclampsia is associated with an increased risk of later dementia, particularly vascular dementia, caused by reduced blood supply to the
Home » Alzheimer's »
Researchers develop combined data model to better evaluate for mild cognitive impairment
A new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status
Alzheimer’s Gene Tied to ‘Chemo Brain’ in Breast Cancer Survivors
WEDNESDAY, Oct. 3, 2018 — Many older breast cancer patients might worry that they will be struck by “chemo brain”
A biomarker in the brain’s circulation system may be Alzheimer’s earliest warning: Breakdown of blood vessel lining is seen in multiple neurodegenerative diseases
USC scientists say Alzheimer’s could be diagnosed earlier if scientists focus on an early warning within the brain’s circulation system.
Artificial anti-oxidant may be the next go-to supplement: Study shows TEMPO is up to 100 times more powerful than vitamin E
Naturally-derived anti-oxidants have become the ‘it’ health ingredient to look for in food. But researchers from UBC Okanagan and the
Can daytime sleepiness predict Alzheimer’s?
Alzheimer’s disease is the most common form of dementia. It affects around 5.7 million people in the United States —
Earlier diagnosis, potential therapy for Huntington’s disease suggested in new research
A new study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that Huntington’s disease may take
Now we can see brain cells ‘talk’ and that will shed light on neurological diseases
Scientists have developed a way to see brain cells talk — to actually see neurons communicate in bright, vivid color.
Study raises the standard for measuring nerve cell death: Research improves screening of experimental therapies for neurodegenerative disease
Researchers at UBC’s Okanagan campus have developed a new and improved method to judge the effectiveness of experimental therapies for
First-of-its-kind Parkinson’s biomarker guidelines invigorates drive for treatments: Creating guidelines for discovering Parkinson’s biomarkers is key to developing treatments
Parkinson’s disease affects more than 4 million people worldwide, with numbers projected to double in the next few decades. With